Salix Sinks In #PreMarket On Disappointing Outlook, Q2 Results
August 08, 2014 at 09:19 AM EDT
Salix Pharmaceuticals (NASDAQ: SLXP) fell in pre-market action Friday on a disappointing outlook and second-quarter results. Net ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.